Skip to main content
Log in

Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors

  • Original article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to evaluate the incidence and predictors of seed migration after transperineal interstitial prostate brachytherapy.

Materials and methods

From March 2007 to March 2011, 121 patients with stage T1–T2 prostate cancer underwent transperineal interstitial prostate brachytherapy. Pre-planning was performed 3 weeks prior to implantation, and the implants were inserted using the standard parallel needle insertion technique. All patients underwent a series of radiographs [chest radiography, kidney–ureter–bladder (KUB) radiography, and a CT scan] to assess whether seed migration had occurred on postoperative days 1 and 30, and 12 months.

Results

Seed migration occurred in 31 (25.6 %) of 121 patients. A total of 51 of 7,883 (0.65 %) implanted seeds migrated. Migration was detected on postoperative day 1 in 16 patients, day 30 in 13 patients and at 12 months in 4 patients (migration occurred at different times in 2 patients). The migrated seeds were found in the lungs, pelvis, heart, mediastinum, kidney, inguinal canal, liver and sacrum. The number of needles was a statistically significant factor in seed migration.

Conclusions

The seeds migrated to many organs. No decrease in the dose administered to the prostate or adverse effects associated with seed migration were noted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Reference

  1. Blair HF, Porter A, Chen QS. In vivo detection of an 125I seed located in the intracardiac region after prostate permanent brachytherapy. Int J Radiat Oncol Biol Phys. 2004;58:888–91.

    Article  PubMed  Google Scholar 

  2. Davis BJ, Bresnahan JF, Stafford SL, Karon BL, King BF, Wilson TM. Prostate brachytherapy seed migration to a coronary artery found during angiography. J Urol. 2002;168:1103.

    Article  PubMed  Google Scholar 

  3. Davis BJ, Pfeifer EA, Wilson TM, King BF, Eshleman JS, Pisansky TM. Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. J Urol. 2000;164:1661.

    Article  PubMed  CAS  Google Scholar 

  4. Kunos CA, Resnick MI, Kinsella TJ, Ellis RJ. Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator. Brachytherapy. 2004;3:71–7.

    Article  PubMed  Google Scholar 

  5. Older RA, Synder B, Krupski TL, Glembocki DJ, Gillenwater JY. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J Urol. 2001;165:1590–2.

    Article  PubMed  CAS  Google Scholar 

  6. Stone NN, Stock RG. Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy. Urology. 2005;66:119–23.

    Article  PubMed  Google Scholar 

  7. Sugawara A, Nakashima J, Kunieda E, Nagata H, Mizuno R, Seki S, et al. Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds. Radiat Oncol. 2011;6:130–40.

    Article  PubMed  Google Scholar 

  8. Nag S, Vivekanandam S, Martínez-Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1997;39:667–70.

    Article  PubMed  CAS  Google Scholar 

  9. Sommerkamp H, Rupprecht M, Wannenmacher M. Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. Int J Radiat Oncol Biol Phys. 1988;14:389–92.

    Article  PubMed  CAS  Google Scholar 

  10. Miura N, Kusuhara Y, Numata K, Shirato A, Hashine K, Sumiyoshi Y, et al. Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung. Jpn J Clin Oncol. 2008;38:623–5.

    Article  PubMed  Google Scholar 

  11. Nguyen BD. Cardiac and hepatic seed implant embolization after prostate brachytherapy. Urology. 2006;68:673.e17–19.

    Google Scholar 

  12. Zhu AX, Wallner KE, Frivold GP, Ferry D, Jutzy KR, Foster GP. Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarction. Brachytherapy. 2006;5:262–5.

    Article  PubMed  Google Scholar 

  13. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy. 2009;8:309–12.

    Article  PubMed  Google Scholar 

  14. Nakano M, Uno H, Gotoh T, Kubota Y, Ishihara S, Deguchi T, et al. Migration of prostate brachytherapy seeds to the vertebral venous plexus. Brachytherapy. 2006;5:127–30.

    Article  PubMed  Google Scholar 

  15. Nguyen BD, Egnatios GL. Prostate brachytherapy seed migration to the left testicular vein. Brachytherapy. 2010;9:224–6.

    Article  PubMed  Google Scholar 

  16. Khurshid I, Downie GH. Pulmonary arteriovenous malformation. Postgrad Med J. 2002;78:191–7.

    Article  PubMed  CAS  Google Scholar 

  17. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47:440–5.

    Article  PubMed  Google Scholar 

  18. Wan G, Wei Z, Gardi L, Downey DB, Fenster A. Brachytherapy needle deflection evaluation and correction. Brachyth Med Phys. 2005;32:902–9.

    Article  Google Scholar 

  19. Wei Z, Gardi L, Downey DB, Fenster A. Oblique needle segmentation and tracking for 3D TRUS guided prostate brachytherapy. Med Phys. 2005;32:2928–41.

    Article  PubMed  Google Scholar 

  20. Sugawara A, Nakashima J, Shigematsu N, Kunieda E, Kubo A. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds. Brachytherapy. 2009;8:52–6.

    Article  PubMed  Google Scholar 

  21. Ankem MK, DeCarvalho VS, Harangozo AM, Hartanto VH, Perrotti M, Han K, et al. Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology. 2002;59:555–9.

    Article  PubMed  Google Scholar 

  22. Eshleman JS, Davis BJ, Pisansky TM, Wilson TM, Haddock MG, King BF, et al. Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration. Int J Radiat Oncol Biol Phys. 2004;59:419–25.

    Article  PubMed  Google Scholar 

  23. Fuller DB, Koziol JA, Feng AC. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. Brachytherapy. 2004;3:10–9.

    Article  PubMed  Google Scholar 

  24. Merrick GS, Butler WM, Dorsey AT, Lief JH, Benson ML. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:215–20.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katsuhito Miyazawa.

About this article

Cite this article

Miyazawa, K., Matoba, M., Minato, H. et al. Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors. Jpn J Radiol 30, 635–641 (2012). https://doi.org/10.1007/s11604-012-0102-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-012-0102-7

Keywords

Navigation